
»ù±¾ÇéÐÎ
·ëÄÈ£¬Å®£¬Öй²µ³Ô±¡£¡£¡£ÏÖÈÎÒ¼ºÅÓéÀÖAPPҩѧÓëʳÎ﹤³ÌѧԺרÈÎÎ÷ϯ¡£¡£¡£
ÁªÏµ·½Ê½
µØµã£º£º¹ã¶«Ê¡½ÃÅÊÐÅî½Çø¶«³É´å22ºÅ Ò¼ºÅÓéÀÖAPPҩѧÓëʳÎ﹤³ÌѧԺ
Óʱࣺ£º529020
ÓÊÏ䣺£ºwyuchemfn@126.com
ÊÂÇéÂÄÀú
2018Äê7ÔÂÖÁ½ñ£¬Ò¼ºÅÓéÀÖAPP£¬Ò©Ñ§ÓëʳÎ﹤³ÌѧԺ£¬Ë¶Ê¿Éúµ¼Ê¦
2015Äê11ÔÂÖÁ2018Äê6Ô£¬ÃÀ¹úµÂ¿ËÈøË¹´óѧÎ÷ÄÏҽѧÖÐÐÄ£¬²©Ê¿ºó
2009Äê3ÔÂÖÁ2009Äê6Ô£¬Öйúũҵ¿ÆÑ§ÔºÖ²Îï±£»¤Ñо¿Ëù£¬Ñо¿ÖúÀí
2005Äê9ÔÂÖÁ2008Äê12Ô£¬±±¾©ÉúÃü¿ÆÑ§Ñо¿Ëù£¬Ñо¿ÖúÀí
½ÌÓý¼°Ñ§Ï°ÂÄÀú
2009Äê9ÔÂ-2016Äê6Ô£¬À¼ÖÝ´óѧÉúÃü¿ÆÑ§Ñ§Ôº£¬Ë¶Ê¿¡¢¡¢¡¢²©Ê¿
2001Äê9ÔÂ-2005Äê6Ô£¬»ªÖÐũҵ´óѧÉúÃü¿ÆÑ§ÓëÊÖÒÕѧԺ£¬Ñ§Ê¿
Ö÷ÒªÑо¿Æ«Ïò
1. ¿¹ÅÁ½ðɲ¡Ð¡·Ö×Ó»¯ºÏÎïµÄ»îÐÔ¼ì²â¼°»úÖÆÑо¿
2. ¼×È©¶¾ÐÔÓ°ÏìÉñ¾ÍËÐÐÐÔ¼²²¡µÄ×÷Óü°»úÖÆÑо¿
3. ¿¹Ñõ»¯¿¹ÐàÂõС·Ö×Ó»¯ºÏÎïµÄɸѡ¼°»úÖÆÑо¿
½ÒÏþѧÊõÂÛÎÄ
1. Chen MT, Zhou JJ, Han RT, Ma QW, Wu ZJ, Fu P, Ma AJ, Feng N. Melatonin derivative 6a protects Caenorhabditis elegans from formaldehyde neurotoxicity via ADH5. Free Radic. Biol. Med., 2024,223,357-368.
2. Ma QW, Han RT, Wu ZJ, Zhou JJ, Chen MT, Zhang XZ, Ma WZ, Feng N. Melatonin derivative 6a as a PARP-1 inhibitor for the treatment of Parkinson¡¯s disease. Front Pharmacol., 2024,15,1363212.
3. He L, Du J, Chen M, Zhou J J, Luo L, Li B Q, Zhang X Z, Ma W Z, Ma A J and Feng N. Synthesis of melatonin derivatives and the neuroprotective effects in Parkinson's disease models of Caenorhabditis elegans. Front Chem., 2022, 10:918116.
4. He L, Chen MT, Zhou JJ, Luo L, Feng N And Ma AJ. Synthesis of Novel Melatonin Derivatives and Investigation of their Antioxidant Activity. Chin. J. Syn. Chem., 2022, 03, 1-13.
5. Shen Y, Guo K, Ma A, Huang Z, Du J,Chen J, Lin Q, Wei C, Wang Z, Zhang F, Zhang J, Lin W, Feng N and Ma W. Mitochondrial toxicity evaluation of traditional Chinese medicine injections with a dual in vitro approach. Front. Pharmacol., 2022,13,1039235.
6. Qiu ZW, Xu XT, Pan HP, Jia ZS, Ma AJ, Peng JB, Du JY, Feng N, Li BQ, Zhang XZ. Br?nsted Acid-Catalyzed Formal (3+3)-Annulation of Propargylic (Aza)-para-Quinone Methides with 4-Hydroxycoumarins and 1,3-Dicarbonyl Compounds. J. Org. Chem., 2021, 86, 6075-6089.
7. Feng N, Simanski S, Islam K, Hynan LS, Kodadek T, German DC. Antibody biomarker for de novo Parkinson disease: attempted validation. NPJ Parkinsons Dis., 2018, 4, 28.
¼ÓÈëѧÊõ¾Û»á¼°ÂÛÎÄ
ÑÇÖÞ×ÔÓÉ»ùÑо¿¹ú¼Ê¾Û»áôß 2024 ÖйúÑõ»¯»¹ÔÉúÎïѧÓëҽѧ´ó»á£¬2024.10£¬±±¾©
¹ã¶«Ê¡ÖÐҽҩѧ»áÖÐҩʵÑéÒ©ÀíרҵίԱ»á³ÉÁ¢´ó»áôßѧÊõ¾Û»á£¬2023.4£¬¹ãÖÝ
2023Ä꿹ÐàÂõ¹ú¼ÊѧÊõ×êÑлᣬ2023.6£¬ÖÐɽ
2023ÄêÖйúÑõ»¯»¹ÔÉúÎïѧÓëҽѧ´ó»á£¬2023.8£¬ÏÃÃÅ
2023ÄêµÚÆß½ìÌìÏÂÐãÀöÏß³æPIѧÊõ×êÑлᣬ2023.10£¬Çൺ
ÉêÇë¼°ÊÚȨרÀû
1. ·ëÄÈ,ÂÞ·,³ÂÃÎæÃ,ÖÜ¿¡½Ü,ÂíÇìΰ,º«ÈðæÃ,Öì־ǿ.ßÁà«À໯ºÏÎïÔÚÖÆ±¸ÓÃÓÚÔ¤·ÀºÍ/»òÖÎÁÆÅÁ½ðɲ¡Ò©ÎïÖеÄÓ¦ÓÃ[P]. ZL202211337036.X
2. ·ëÄÈ,ÂÞ·,ÖÜ¿¡½Ü,³ÂÃÎæÃ,³ÂÓ³Ö®,ÑîÃÎÔ²,ÎÄ»ÛÐÄ,Ñӯ.Ò»ÖÖ°×ÑîËØÑÜÉúÎïµÄÖÆ±¸ÒªÁì[P]. ZL202211335765.1
3. ·ëÄÈ,ºØÀû,ÑîÃÎÔ²,Τ¶¬Ã·,Âí°®¾ü.Ò»ÖÖ°×ÑîËØÈâ¹ðËáõ¥»òÆäÑÜÉúÎï¼°ÆäÖÆ±¸ÒªÁì[P]. ZL202010891873.1
4. Âí°®¾ü,Áºç²Ã÷,Å·æÃæÃ,Ö£¾°ÔÆ,Àî·ïƼ,¬˼Զ,·ëÄÈ£¬³Â´ºÁ飬ÓÎËÉÌÎ.2-ÒÒ»ù-3,4-¶þÇâ-1(2H)-ÒìàßøÍªµÄÖÆ±¸ÒªÁì[P]. ZL202110688971.X
5. ·ëÄÈ,ºØÀû,ÂÞ·,ÖÜ¿¡½Ü,³ÂÃÎæÃ,ÎÄ»ÛÐÄ,Âí°®¾ü.Ò»ÖÖÍʺڼ¤ËØÈâ¹ðËáÑÜÉúÎï¼°ÆäÖÆ±¸ÒªÁì[P]. ZL202210518275.9
6. ÀîºìÓñ, °²ÀèÕÜ, Ö§µÂ¾ê, ÀîÑó, ·ëÄÈ, ¹ùçàçà, ÍõÓµÈ. ·¢½ÍÉú²ú¶þ¾ÛÌ廯ÈÚºÏÂѰ׵ÄÒªÁì[P]. ZL104046642B
»ñ½±¼°ÉùÓþ
µÚ¶þʮһ½ìѧÊõ¿Æ¼¼½ÚÖ®Éú»¯´óÈüÓÅÒìÖ¸µ¼ÏÈÉú£¬2021.5
2021-2022ѧÄê¶È¡°ÓÅÒìѧҵָµ¼Ê¦¡±£¬2022.6
2021-2022ѧÄê¶È¡°ÓÅÒì°àµ¼Ê¦¡±£¬2022.9
½ÃÅÊÐ¿ÆÆÕ½²Ê¦ÍųÉÔ±